Highest-materiality recent filing
Scotts Miracle-Gro Q3 adj EPS $2.82 (+8% YoY); raises FY guidance to $4.30-$4.45
Net sales $1.17B (+1% YoY); GAAP EPS $1.75 (-34% YoY) due to impairment/restructuring.
Nate Baxter named CEO of Scotts Miracle-Gro, succeeding Jim Hagedorn; FY2026 guidance reaffirmed
Nathan E. Baxter appointed President & CEO effective June 26, 2026; also elected to Board.
Scotts Miracle-Gro Q2 net sales +5% to $1.46B; adj. EPS $4.53 beats $4.00 YoY
GAAP diluted EPS from continuing ops $4.46 vs $3.78; adjusted EPS $4.53 vs $4.00, up 13%.
ScottsMiracle-Gro sells Hawthorne to Vireo for 213M shares plus warrants
Consideration: 213M subordinate voting Vireo Shares and warrants for 80M additional shares.
Scotts Miracle-Gro reclassifies Hawthorne as discontinued ops for sale; revises prior financials
Hawthorne business classified as held for sale in Q1 2026; results reclassified as discontinued operations.
Scotts Miracle-Gro reports Q1 net loss of $0.83/sh, announces Hawthorne sale to Vireo, $500M buyback
U.S. Consumer net sales $328.5M; GAAP gross margin 25.0% (+90 bps); net leverage improved to 4.03x.
SMG FY2025 adj EPS $3.74, gross margin up 490 bps; guides FY2026 adj EPS $4.15-$4.35
FY2025 adj EPS $3.74 vs $2.29 prior year; GAAP EPS $2.47 vs ($0.61) prior year.
Scotts Miracle-Gro Q3 GAAP EPS $2.54, adj. EPS $2.59; reaffirms FY guidance
GAAP net income $149.1M ($2.54/diluted share) vs. $132.1M ($2.28) a year ago; non-GAAP adj. $151.5M ($2.59).
Scotts Miracle-Gro Q2 GAAP EPS $3.72; adjusted EBITDA $402.8M, reaffirms guidance
Q2 GAAP EPS $3.72 vs $2.74 prior year; adjusted EPS $3.98 vs $3.69.
Scotts Miracle-Gro Q1 adj. EBITDA improves $30M; reaffirms FY guidance; lowers interest expense view
Q1 net loss $69.5M ($1.21/sh) vs $80.5M ($1.42/sh) YoY; adj. loss $0.89/sh improved $0.56.
Full-year revenue $3.6B flat; U.S. Consumer up 6% to $3.0B; Hawthorne down 37% to $294.7M.
Scotts Miracle-Gro Q3 adjusted EPS $2.31 doubles YoY; U.S. Consumer sales up 11%
GAAP EPS $2.28 vs $0.77; Non-GAAP adjusted EPS $2.31 vs $1.17, more than doubling YoY.
ScottsMiracle-Gro Q2 GAAP EPS $2.74, adj. EPS $3.69; reaffirms FY2024 targets
Q2 net sales flat at $1.53B; U.S. Consumer record $1.38B (+2% YoY); Hawthorne down 28% to $66.4M.
ScottsMiracle-Gro expects Q2 net leverage ratio ~7x, below covenant max of 7.75x
Q2 net leverage ratio expected ~7x adjusted EBITDA, below Q1 level and covenant max of 7.75x.
Scotts Miracle-Gro Q1 GAAP loss $1.42/sh; sales down 22%; reaffirms FY24 EBITDA $575M
Q1 net loss $80.5M ($1.42 GAAP loss/sh); non-GAAP loss $1.45/sh vs. $1.02 loss a year ago.
Scotts Miracle-Gro reports fiscal 2023 results and enters $600M receivables facility with JPMorgan
Full-year net sales $3.55B (-10% YoY); GAAP net loss $380.1M ($6.79 loss per share).
Michael C. Lukemire, former President, left October 1, 2023; separation agreement executed October 6, 2023.
Mike Lukemire steps down as COO on Sept 3, 2023, will retain President role until retirement in fiscal 2024.
Scotts Q3 adjusted EPS $1.17 vs $1.98; sales -6%; full-year guidance cut; credit amended
Q3 GAAP EPS $0.77 vs prior year loss; adjusted EPS $1.17 vs $1.98; sales $1.12B (-6% YoY).
Scotts Miracle-Gro Q2 GAAP EPS $1.94, adj. EPS $3.78; revenue down 9% YoY; leverage at 6.0x
GAAP EPS $1.94, adjusted EPS $3.78; prior year GAAP $4.94, adj. $5.03.
Expects Q2 net leverage of ~6.0x, comfortably below the 6.5x credit facility covenant.
Scotts Miracle-Gro Q1 GAAP loss $1.17/sh; U.S. Consumer +8%, Hawthorne -31%; guidance updated
GAAP net loss $64.7M ($1.17/sh); non-GAAP adj. loss $1.02/sh vs year-ago loss $0.90/sh.
Scotts Miracle-Gro names Matthew Garth as CFO effective Dec 1; Evans steps down
Matthew Garth appointed EVP and CFO, effective December 1, 2022; previously CFO of Minerals Technologies.
Q4 sales fell 33% to $493.6M; U.S. Consumer -18%, Hawthorne -49%.
CFO Cory J. Miller departs Scotts Miracle-Gro; severance includes 24-month salary and 2x bonus
CFO Cory J. Miller separated August 29, 2022; effective September 1, 2022.
CFO Cory Miller departed effective Aug 29 by mutual agreement, treated as involuntary termination without cause.
Scotts Miracle-Gro Q3 sales down 26%; GAAP EPS loss of $8.01; cuts FY guidance
Company-wide Q3 sales $1.19B (-26% YoY); U.S. Consumer -14%, Hawthorne -63%.
Scotts Miracle-Gro Q2 GAAP EPS $4.94 vs $5.44; guides to low end of sales; acquires Cyco
GAAP EPS from continuing ops $4.94 vs $5.44; non-GAAP adj EPS $5.03 vs $5.64.
On January 31, 2025, the Board, upon the recommendation of the Nominating and Governance Committee of the Board (“Nominating Committee”), appointed Nick Miaritis as a Class II member of the Board to fill a vacancy arising from Mr. Kelly’s departure.
On January 27, 2025, Tom Kelly, a member of the Board of Directors (the “Board”), notified The Scotts Miracle-Gro Company (the “Company”) of his resignation from the Board with his term ending January 31, 2025.
On November 4, 2024, the Board, upon the recommendation of the Nominating and Governance Committee of the Board (“Nominating Committee”), appointed Roberto Candelino as a Class I member of the Board to fill a vacancy.
On January 25, 2024, Nancy Mistretta, a member of the Board of Directors (the “Board”), notified The Scotts Miracle-Gro Company (the “Company”) of her resignation from the Board effective January 30, 2024.
On September 27, 2023, The Scotts Miracle-Gro Company (the “Company”) reported that Denise Stump, the Company’s former Executive Vice President, Global Human Resources and Chief Ethics Officer, would be departing the Company on October 1, 2023 (the “Termination Date”).
On September 27, 2023, The Scotts Miracle-Gro Company (the “Company”) reported that Michael C. Lukemire, the Company’s former President, would be departing the Company on October 1, 2023 (the “Termination Date”).
On September 25, 2023, the Company and each of Michael C. Lukemire and Denise Stump mutually agreed to an acceleration of their retirement from the Company effective October 1, 2023.
the Board elected Jim Hagedorn, our Chairman and Chief Executive Officer, to the additional title of President.
On September 25, 2023, the Company and each of Michael C. Lukemire and Denise Stump mutually agreed to an acceleration of their retirement from the Company effective October 1, 2023.
The Board also elected Matthew E. Garth, our current Executive Vice President and Chief Financial Officer, to the additional title of Chief Administrative Officer.
In a corresponding move as part of the plan, the Board of Directors appointed Nathan Baxter as Executive Vice President & Chief Operating Officer, effective September 4, 2023, reporting to Mr. Lukemire, who will mentor and guide Mr. Baxter in the COO transition.
Mr. Lukemire will step down from his COO role on September 3, 2023, and retain his position and responsibilities as President, reporting to Mr. Hagedorn, until his planned retirement in fiscal 2024.
Max materiality 0.85 · Median 0.62 · Most common event earnings